SynthesisBMC cancer2024

Dabrafenib plus trametinib in low-grade versus high-grade gliomas: a systematic review and meta-analysis.

Bardia Hajikarimloo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.